 HemOncToday | Everolimus improved PFS in patients with metastatic, ER-positive breast cancer HemOncToday SAN ANTONIO — Adding everolimus to exemestane in postmenopausal patients with ER-positive advanced breast cancer improved PFS, according to research presented here. Study researcher Gabriel N. Hortobagyi, MD, FACP, professor of medicine and chair of ... SABCS: Breast Cancer Survival Up With Everolimus + Exemestane SABCS: Addition of Everolimus Helps Slow Breast Cancer BOLERO-2: Everolimus Plus Exemestane Delays Breast Cancer Progression |
